Developing a cold vaccine has long been dismissed as implausible because colds are caused by many different viruses, each of which is highly susceptible to mutations. (Photo: Shutterstock)
Is there any limit to what Amazon can do? The company had its work cut out for it when the tech giant announced it was entering the health care space, but apparently reforming the drug supply chain and how care is delivered just wasn't enough. The company's latest ambition? Working on a vaccine to prevent the common cold.
The news, reported Friday by CNBC, is understandably overshadowed by coronavirus, a disease that researchers are scrambling to develop a vaccine for.
Recommended For You
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
